Table 2.
OOC | Sources | Application | Scaffold | Microfluidic chip fabrication | Key findings | Vessel characteristics | Reference |
---|---|---|---|---|---|---|---|
Brain | hiPSCs | BEM and microfluidic device to improve the structural and functional maturation of human brain organoid | BEM, Matrigel | technique: soft lithography materials: PDMS solution and Sylgard 184 (10:1 ratio) molding: 2.2 mm on patterned master holes: 8-mm diameter, punched bonding: oxygen plasma assembly: stacked PDMS layers with bottom seal sterilization: autoclaved, UV dried flow: rocker system D, 8 mm; H, 0.33 mm; W, 0.9 mm |
|
N/A | 150 |
hiPSCs, MCF-7 | investigating the impact of exosomes derived from breast cancer cells on brain neurodevelopment | Matrigel | material: PDMS technique: soft lithography structure: two layers; bottom with 1 mm micropillars, top with a 24-well plate ring process: mix PDMS and curing agent (10:1), degas, cure at 80°C (40–60 min), peel off mold |
|
N/A | 151 | |
Intestine | HUVECs, mouse ISCs | perfusable mini-gut tubes from stem cells that mimic the intestine’s structure and functions | collagen I, Matrigel | compartments: central hydrogel chamber for organoid culture. Basal side reservoirs for medium diffusion. Inlet/outlet reservoirs for perfusion design features: phase-guiding with semi-walls and pillars. Extra port for hydrogel loading fabrication: designed with CleWin, patterned on silica molded with SU8 photoresist, then PDMS. Plasma-treated PDMS bonded to glass dishes sterilization: cleaned, UV sterilized, and stored sterile |
|
N/A | 152 |
hiPSCs and HIMECs the epithelial cells were derived from duodenal organoids |
– | collagen I, Matrigel | method: Photolithography and demolding of cured PDMS from a master mold PDMS ratio: 15:1 (prepolymer to curing agent) dimensions: cell culture channel (1 × 10 × × 0.15 mm), vacuum chambers (1.68 × 9.09 × × 0.15 mm), wall thickness 100 μm porous membrane: made by casting PDMS over micropatterned silicon, then overlaid and cured with a silanized PDMS slab assembly: bonded with corona plasma treatment; vacuum chambers formed by removing membrane sections bonding: final assembly cured at 80°C for permanent bonding tubing: silicone tubing with connectors for medium and suction flow: monolayer formation achieved with physiological fluid flow (60 μL/h) chip activation: intestine chip subjected to peristalsis-like motions mechanical stimulation: 10% strain at 0.2 Hz, applied via cyclic suction to side chambers |
|
|
153 | |
Kidney | H9 hESCs, hiPSCs, hGMECs, HUVECs | culturing kidney organoids under millifluidic conditions | gelatin-fibrin | ink: two-part silicone elastomer, 10:1 ratio, homogenized 3D printing: custom perfusion gaskets, using a bioprinter with a 410-μm nozzle features: gaskets on glass, organoid chamber (15 × 3.6 × × 60 mm), 1 mm ECM organoids: space for 4–20 per chip, in 8 × 3.6 × × 20-mm area curing: 80°C, then autoclaved FSS range: low FSS (1 × 10−7 to 1 × 10−4 dyn/cm2), High FSS (8 × 10−3 to 3.5 × 10−2 dyn/cm2) |
|
|
154 |
Liver | HepaRG, HUVECs, monocyte-derived macrophages, LX-2 (stellate cell line) | – | PET | material: COC - TOPAS from microfluidic ChipShop perfusion: silicone tubing for oxygen chip body dimensions: 75.5 mm (L) × 22.5 mm (W) × 1.5 mm (H) upper channel dimensions: 15.0 mm (L) × 2 mm (W) × 0.45 mm (H) lower channel dimensions: 16.8 mm (L) × 2 mm (W) × 0.40 mm (H) membrane dimensions: 13 mm (L) × 8.5 mm (W) × 0.02 mm (H), with 8-μm pore diameter membrane distances: to upper sealing foil: 0.7 mm to lower sealing foil: 0.8 mm flow rates and shear stress: upper channel: 50 μL/min, shear stress: 0.7 (dyn∗s)/cm2 lower channel: 1 μL/min, shear stress: 0.01 (dyn∗s)/cm2 |
|
|
155 |
HepG2/C3A | liver-on-a-chip platform for long-term culture of 3D human liver spheroids | PMMA, PDMS | multilayer chips: PDMS-membrane-PDMS sandwich structure for spheroid culture; uses PET microporous membrane (3 μm pores, 2 × 106 pores/cm2) for observation upper fluidic layer: designed in AutoCAD, made with soft lithography (2,000 × 200 μm channels) from SU8-2075 on silicon, using PDMS (10:1) lower microwell layer: CNC-milled PMMA master creates 1,080 microwells, converted into a smooth PDMS mold via a secondary PDMS-coating technique, then final PDMS molding (10:1) cured at 80°C for smooth concave microwells |
|
N/A | 156 | |
Lung | lung cancer tissue (surgical resection) | culturing 3D lung cancer organoids and conducting drug sensitivity tests within a single system | Matrigel | 3D culture methods: includes hanging-drop, biopolymer encapsulation, perfusion bioreactors, and cell sheet layering MPS platform: PDMS-based microfluidic channels for streamlined cell seeding and drug testing design: 29-well device with wells 750 μm deep and 500 μm wide flow: organoids mixed with Matrigel and medium, centrifugally loaded into wells, with a yarn capillary to regulate flow at 2–5 mL/day |
|
N/A | 157 |
A549, HUVECs, NHLFs | a microphysiological system to model lung cancer by combining 3D tumor spheroids with a self-assembled, perfusable microvasculature | fibrin | fabrication: used soft lithography for PDMS medium reservoir and channel slab dimensions: culture chamber 1,600 × 400 μm, microchannels 400 × 400 μm, reservoir 12 × 12 × × 4 mm process: mixed PDMS with curing agent (10:1), cured at 65°C, added ports, assembled with spin-coated PDMS, and re-cured ECM coating: incubated microchannels with fibronectin solution (25 μg/mL) for 3 h at 37°C channel washing: washed once with EGM-2 cell seeding: introduced 10-μL HUVEC suspension (1 × 107 cells/mL) into channels, allowed attachment for 3 h perfusion setup: connected external reservoirs and syringe pump, set flow rate to 70 μL/h |
|
|
158 | |
Neurovascular | hiPSC-derived ECs, pericytes, and neuroepithelial cells | co-culture of vascular cells and cerebral organoids on a 3D printed microfluidic chip | Matrigel | perfusion: connected to Chemyx pump, perfused at 2 μL/min solution: 1 μm RF-BEADS (1:1,000), fluorescein-40-kDa dextran (500 μg/mL) in PBS visualization: epifluorescence and confocal microscopy for beads and dextran |
|
|
159 |
Pancreas | hiPSCs | islet-on-a-chip model generated from heterogeneous hiPSC-derived islet organoids | Matrigel | design: multilayer microfluidic chip for islet organoid generation composition: top and bottom PDMS layers, through-hole PDMS membrane, polycarbonate porous membrane function: 3D culture of EBs, media perfusion, interconnected flow between upper and bottom channels flow: continuous culture medium was injected at 100 μL/h advantage: circulatory flow for efficient medium exchange and uniform fluid stress on organoids |
|
N/A | 160 |
Placenta | primary EVTs, ECs, stromal cells, and uNK cells (endometrial biopsies) | implantation-on-a-chip to mimic the 3D organization of the maternal-fetal interface and model the invasion of EVT into the uterus and spiral artery remodeling during implantation | collagen, Matrigel | Fabrication: Soft lithography with PDMS on an SU-8 master for microchannels. design model is a 3D microfluidic device consisting of three parallel lanes: ECM, simulating specialized maternal endometrium; vascular chamber consisting of human uterine ECs, simulating maternal spiral artery; fetal section consisting of human EVTs assembly: sealed with a PDMS layer; top layer includes 7-mm media reservoir holes sterilization: UV irradiated for 20 min surface prep: poly(dopamine) coating for ECM hydrogel attachment, then rinsed and dried |
|
|
161 |
Prostate | LNCaP, PC3 | PCa-MPS model to recapitulate epithelial features of PCa and CRPC cells and their PSA and miRNA secretion | agarose, collagen I | chip used: HUMIMIC Chip2 MPS (TissUse, Berlin, Germany) cells cultured: LNCaP and PC3 under dynamic conditions setup: two gels per perfusion circuit in the chip’s culture chambers media: 250 μL per chamber, perfused at 1 Hz for 4 days analysis: supernatant and cell samples collected from conventional, 3D static, and dynamic MPS cultures |
|
N/A | 162 |
Retina | hiPSC (RPE and RO) | a retina-on-a-chip model that mimics human retinal functions and interactions, aiming to advance drug testing and research into retinal diseases | hyaluronic acid | platform: microfluidic for hiPSC-derived RPE and RO culture with physiological structure configuration: four micro-tissues linked by microchannel, in two-layered biocompatible polymers layers: top for RO/RPE compartments, bottom for nutrient perfusion barrier: porous membrane for nutrient exchange, protects from shear forces procedure: seed RPE cells, culture 24 h inject ROs in hyaluronic hydrogel to separate from RPE culture: initiated for 3 days, stable up to 21 days for analysis or further experiments |
|
N/A | 163 |
hESCs (H9 and CSC14) | development and validation of a shear stress-free micro-millifluidic bioreactor to standardize and automate the maintenance of retinal organoids | Matrigel | design: SolidWorks-created mold with 200-μm channels and 2-mm chambers in a 6 × 5 array for RtOg culture, compatible with 96-well plates 3D printing: Formlabs form 3B, clear resin; post-processed with isopropanol, air-dried, UV cured fabrication: PDMS cast in 10:1 ratio, degassed, cured at room temperature over the mold assembly: PDMS demolded, ports punched, air plasma-treated, bonded to a glass coverslip |
|
N/A | 164 | |
Vascular | NC8 (hiPSCs), HUVECs | a microfluidic platform to cultivate and vascularize 3D cell aggregates | collagen I-Matrigel | device material: COC for durability, mass production, optical clarity, and chemical stability chip design: 10 microchannels, monitored with a 10-channel syringe pump encapsulation method: adapted hydrodynamic trapping for precise organoid placement within serpentine-shaped microchannels organoid positioning: fibrin hydrogel-embedded organoids accurately located at trap sites, maintaining morphology trap dimensions: adjustable based on organoid size; e.g., BVOs (Ø 600 μm, width 300 μm, height 800 μm), spheroids (Ø 300 μm, width 200 μm, height 400 μm) |
|
|
165 |
BEM, brain ECM; CRPC, castration-resistant prostate cancer; BVO, blood vessel organoid; EVT, extravillous trophoblast; HIMECs, human intestinal microvascular ECs; LCO, lung cancer organoid; LNCaP, lymph node metastatic cancer prostate cell line; ISCs, intestinal stem cells; uNK, uterine natural killer; RtOg, retinal organoid.